Adagene Inc. (ADAG)

Verve Therapeutics Revenue

In the year 2024, Adagene had annual revenue of $103.20K, down -99.43%. Adagene had revenue of $103.20K in the half year ending December 31, 2024, a decrease of -98.08%.

• Revenue (ttm): $103.20K
• Revenue Growth: -99.43%
• P/S Ratio: 876.42
• Revenue / Employee: $748
• Employees: 138
• Market Cap: 90.45M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	103.20K	-18.01M	-99.43%
Dec 31, 2023	18.11M	8.82M	94.90%
Dec 31, 2022	9.29M	-882.53K	-8.67%
Dec 31, 2021	10.18M	9.47M	1,351.71%
Dec 31, 2020	700.91K	220.91K	46.02%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.